Stephen Friend

From Wikipedia, the free encyclopedia
Stephen Friend at NightScience 2013 in Paris

Stephen H. Friend MD PhD is the president, co-founder and director of Sage Bionetworks.[1][2][3]

Formerly Senior Vice-President at Merck & Co. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996.[4] Much of his research has focused on cancer.[5]

Friend has also held faculty positions at Harvard Medical School and at Massachusetts General Hospital. He received his Bachelor of Arts in philosophy, his Ph.D. in biochemistry and his M.D. from Indiana University.[2]

Recognition

Friend is named an Ashoka Fellow by Ashoka: Innovators for the Public.[6]

Selected bibliography

References

  1. Kaiser, Jocelyn (2012). "Profile Stephen Friend: The Visionary". Science 335 (6069): 651–653. doi:10.1126/science.335.6069.651. PMID 22323794. 
  2. 2.0 2.1 "Sage Bionetworks Seattle | Directors". Archived from the original on 2012-02-11. 
  3. Anon (2008). "Stephen Friend". Nature Reviews Drug Discovery 7 (2): 114. doi:10.1038/nrd2509. 
  4. Nelson, B.; Schadt, E. (2009). "Something wiki this way comes: Stephen Friend and Eric Schadt reveal their vision for an open-access platform in medical research.". Nature 458 (7234): 13. doi:10.1038/458013a. PMID 19262635. 
  5. Kaiser, Jocelyn (2012). "Profile Stephen Friend: The Visionary". Science 335 (6069): 651–653. doi:10.1126/science.335.6069.651. PMID 22323794. 
  6. http://sagebase.org/info/NewsInfoDownloads/SageAshokaRelease6APR2011.pdf

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.